
Sign up to save your podcasts
Or


This podcast addresses the clinical implications of the high cost of the 21-gene assay in women with ER-positive, node-negative breast cancer.
Related Article: Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay
By American Society of Clinical Oncology (ASCO)3.8
3939 ratings
This podcast addresses the clinical implications of the high cost of the 21-gene assay in women with ER-positive, node-negative breast cancer.
Related Article: Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay

14,359 Listeners

139 Listeners

319 Listeners

498 Listeners

58 Listeners

112,751 Listeners

44 Listeners

32 Listeners

195 Listeners

91 Listeners

363 Listeners

253 Listeners

189 Listeners

41 Listeners

613 Listeners